Interviews and Profiles

  1. Heather McCauley, PhD

    Heather McCauley, PhD

    Heather McCauley, Ph.D., Postdoctoral Fellow, Cincinnati Children’s Hospital Medical Center

    Epithelial Cell Biology, Organoids
  2. Maartje van der Heijden

    Maartje van der Heijden

    Maartje van der Heijden, Ph.D. Student, Laboratory for Experimental Oncology and Radiobiology, Academic Medical Center, Amsterdam

  3. Luigi Aloia, PhD

    Luigi Aloia, PhD

    Luigi Aloia, Ph.D., Postdoctoral Fellow, The Gurdon Institute, University of Cambridge

    Epithelial Cell Biology, Organoids
  4. Janet Rossant

    Janet Rossant

    Janet Rossant, Ph.D., Senior Scientist and Chief of Research Emeritus, Hospital for Sick Children

  5. Ana Camelo, PhD

    Ana Camelo, PhD

    Ana Camelo, Ph.D., Research Scientist, Immunology, MedImmune

    • ILCs in chronic diseases
    • Translational ILC research
  6. Joo-Hyeon Lee, PhD

    Joo-Hyeon Lee, PhD

    Joo-Hyeon Lee, Ph.D., Group Leader, University of Cambridge

  7. Jason Young

    Jason Young

    Jason Young, Research Lead, APEX 5 Expedition, University of Edinburgh

    • High-Altitude Research Expeditions
    • Effects of Hypoxia on Neutrophils
  8. Sofie Pattijn

    Sofie Pattijn

    Sofie Pattijn, Co-Founder and Chief Technology Officer, ImmunXperts, Belgium

    • Assay Development
    • Immuno-Oncology Drug Development
  9. Dr. Robert Liwski, MD, PhD

    Dr. Robert Liwski, MD, PhD

    Robert Liwski, M.D., Ph.D., Medical Director, HLA Laboratory at the Queen Elizabeth II Health Sciences Centre

    • Histocompatibility
  10. Fumio Takei, PhD

    Fumio Takei, PhD

    Fumio Takei, Ph.D., Distinguished Scientist, Terry Fox Laboratory and Professor, The University of British Columbia

    • Role of Group 2 Innate Lymphoid Cells (ILC2s) in Allergic Inflammation
    • Identification and Isolation of ILC2s
  11. Bhushan Dharmadhikari

    Bhushan Dharmadhikari, PhD

    Bhushan Dharmadhikari, Ph.D., Research Scholar, National University of Singapore Yong Loo Lin School of Medicine

    • Dendritic cell therapy for cancer
    • CD137 (4-1BB) immunotherapy
  12. Sara McKee

    Sara McKee, PhD

    Sara McKee, Ph.D., Postdoctoral Fellow, University of Queensland

    • Monoclonal antibody therapy for cancer
    • Myeloid-derived suppressor cells